Government Affairs
Refine Search
Pharmaceutical
In order to reduce drug costs, the government-led bidding system for medicine purchased by public hospitals should be cancelled, according to a group of Chinese pharmaceutical business executives, reported by the local China Daily. 6 March 2013
Pharmaceutical
Draft documents limiting the state purchases of foreign medication do not take into account the Russian Federation citizens' rights for affordable and high-quality treatment, according to participants at press conference devoted to the discussion of the draft RF Government Decree (The Pharma Letters passim), posted on the web site of the Association of International Pharmaceutical Manufacturers (AIPM). 22 February 2013
Generics
Ukraine's Association of Pharmaceutical Research and Development, APRAD, has written to the country's President appealing for amendments to some of the proposed moves on the licensing of imports of medicines and the definition of "active pharmaceutical ingredient" that was passed by the Parliament last year (The Pharma Letter August 6, 2012). 18 February 2013
Generics
The planned imposition of restrictions for the public purchase of imported drugs, initiated by the Russian government, may result in the departure of foreign pharmaceutical companies from the Russian market, local analysts and representatives of foreign drugmakers believe. 17 February 2013
Generics
There were mixed reactions from two sides of the US drug industry - research-based and generic drugmakers - to this week's State of the Union message from President Barack Obama. In his annual State of the Union speech on Tuesday, Pres Obama said he would "reduce taxpayer subsidies to prescription drug companies" to rein in the rising cost of Medicare, the $600 billion health care program for the elderly and disabled. 15 February 2013
Pharmaceutical
The US Department of Commerce has recently released data, showing that exports of pharmaceutical products to Iran have decreased by half. This is despite Washington's claims that "punitive measures" have no humanitarian consequences, noted the Iran-based PressTV news service. 11 February 2013
Pharmaceutical
Patent terms for innovative medicines should be extended to compensate for increasing delays in regulatory approval, pharma trade group Medicines Australia chief executive Brendan Shaw will tell the federal government review of Australia's patent system at a public hearing today (February 11). 10 February 2013
Pharmaceutical
New Zealand's Pharmaceutical Management Agency, PHARMAC, has taken a further major step towards forming a national list of hospital medicines that will be available nationwide. The full list is due to be published on July 1, 2013, and will consist of 16 therapeutic groups, made up of around 2,500 medicines. 5 February 2013
Biotechnology
The Australian Federal Coalition's election commitment to restoring transparency, certainty and confidence to the process for listing medicines on the Pharmaceutical Benefits Scheme will benefit Australian patients as well as industry, according to Medicines Australia chief executive Brendan Shaw. 3 February 2013
Biotechnology
Some of the USA's biggest biotechnology companies are lobbying intensively to limit generic competition to their blockbuster drugs, potentially cutting into the billions of dollars in savings on drug costs contemplated in the federal health care overhaul law, says Andrew Pollack writing earlier this week in the New York Times. 31 January 2013
Biotechnology
The UK government's plans to overhaul the National Health Service pricing system for new drugs are poorly explained, leaving clinicians, patients and the drug industry in the dark over how the changes will work, according to a highly critical report released yesterday by Members of Parliament sitting on the House of Commons health select committee. They said it was "unacceptable" that proposed value-based pricing changes were still not explained despite government plans to implement the measures in less than 12 months. 17 January 2013
Biotechnology
Despite having lower expectations for the future, the German biotechnology sector regards its current situation as better than last year. German companies' willingness to invest is increasingly significantly. 16 January 2013
Pharmaceutical
Medical research - and pharmaceutical research as its integral part - can constitute an important footing for Finland's future growth, according to Jussi Merikallio, general manager of trade group Pharma Industry Finland (PIF), noting that a recent PIF survey crystallizes six factors to unleash the growth potential of pharmaceutical research in Finland. 14 January 2013
Pharmaceutical
The Russian government is considering imposing a ban on the participation of foreign drug producers in the tendering for public procurement of drugs in Russia, in the event that at least two similar drugs, produced by local manufacturers are present on the market. The move has been strongly criticized by leading multinationals operating in the country. 10 January 2013
Pharmaceutical
Drugs that do not represent value for money or are medically unproven may be increasingly reaching one of Europe's largest pharmaceutical markets, according to research undertaken by Cambridge sociologist Lawrence King. Prof King and colleagues Dr Piotr Ozieranski (University of Leicester) and Prof Martin McKee (London School of Hygiene and Tropical Medicine) found that multinational drug companies are deploying their massive financial resources to capture stakeholders at every stage of the process for the scientific recommendation of drugs in Poland. 19 December 2012
Biotechnology
The Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA), alongside NIHR Office for Clinical Research Infrastructure (NOCRI) last week hosted senior representatives from the life sciences industry, academic researchers and policymakers at a London conference to discuss and debate the UK's strengths and attractiveness for life science research and development. 25 November 2012
Generics
India's Union Cabinet yesterday endorsed the Group of Ministers' (GoM) recommendations on the National Pharmaceutical Pricing Policy (NPPP), in move that will have ramification not only on the pharmaceutical industry but also on the interests of patients, according to reports in the local press. At present, the government through the NPPA controls the prices of 74 bulk drugs and their formulations. 23 November 2012
Pharmaceutical
A report published yesterday by IMS Health - which shows the slow progress being made on the uptake of new medicines in the UK - has led the chief of the Association of the British Pharmaceutical Industry (ABPI) to call for a more joined up approach to the government's life sciences strategy. 22 November 2012
Generics
India's Associated Chambers of Commerce and Industry (ASSOCHAM) believes that the Supreme Court ruling (3/10/2012) will result in 70% of the Indian pharmaceutical market put under the inconsistent and inefficient cost based price control mechanism of Drug Price Control Order (DPCO) 1995 and all the 348 molecules will be crippled by the disastrous repressions. 22 November 2012
Pharmaceutical
Tonio Borg, the Maltese nominee for the European Commission's health and consumer protection portfolio, sailed through a three-hour Parliamentary vetting this week, despite repeated questioning about his views on abortion and gay rights. A vote on his nomination will be held next week. 14 November 2012
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze